Abstract
A patient developed cholestatic jaundice following therapy with co-trimoxazole. Inadvertent re-challenge with the drug resulted in further clinical and biochemical deterioration, but complete recovery ensued on stopping this drug.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colucci C. F., Lo Cicero M. Letter: Hepatic necrosis and trimethoprim-sulfamethoxazole. JAMA. 1975 Sep 1;233(9):952–953. [PubMed] [Google Scholar]
- Dujovne C. A., Chan C. H., Zimmerman H. J. Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole. N Engl J Med. 1967 Oct 12;277(15):785–788. doi: 10.1056/NEJM196710122771503. [DOI] [PubMed] [Google Scholar]
- Fries J., Siragenian R. Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole. N Engl J Med. 1966 Jan 13;274(2):95–97. doi: 10.1056/NEJM196601132740209. [DOI] [PubMed] [Google Scholar]
- Hermansen K., Baunsgaard P., Heydenreich G., Nielsen G. Leverforandringer efter sulfametoksazol-trimetoprim (Bactrim, Trisural) Ugeskr Laeger. 1976 Feb 9;138(7):422–424. [PubMed] [Google Scholar]
- Macoul K. L. Hepatitis attributed to sulfamethoxazole. N Engl J Med. 1966 Jul 7;275(1):39–39. doi: 10.1056/NEJM196607072750108. [DOI] [PubMed] [Google Scholar]
- Rehman O. U., Keith T. A., Gall E. A. Methyldopa-induced submassive hepatic necrosis. JAMA. 1973 Jun 4;224(10):1390–1392. [PubMed] [Google Scholar]
- Shaw D. J., Jacobs R. P. Simultaneous occurrence of toxic hepatitis and Stevens-Johnson syndrome following therapy with sulfisoxazole and sulfamethoxazole. Johns Hopkins Med J. 1970 Mar;126(3):130–133. [PubMed] [Google Scholar]